Pregnancy, fetal and infant outcomes of pregnancies exposed to eptinezumab compared to two migraine control cohorts unexposed to eptinezumab: a claims database study in the United States

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Other data source
• Data source(s), other:
  Merative Marketscan Commercial Database; Merative MarketScan Multi-state Medicaid Database;
• Data sources (types):
  Administrative healthcare records (e.g., claims)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  No
• Check completeness:
  No
• Check stability:
  No
• Check logical consistency:
  No

Data characterisation

• Data characterisation conducted:
  No

Procedures

No information provided.